Gastrointestinal adverse events Very common (10% or more): Diarrhea (35%), abdominal pain (21%), vomiting (21%), nausea (12%) Common (1% to 10%): Constipation, dyspepsia, gastrointestinal disorder, melena Very rare (less than 0.01%): Abdominal cramps [Ref] Nervous system Very common (10% or more): Headache (37%), dizziness (18%), paresthesia (12%) Common (1% to 10%): Hypertonia, vertigo, taste perversion Frequency not reported : Seizures (with or without pre-existing seizure activity), increase in seizure frequency and/or severity [Ref] Metabolic Very common (10% or more): Hypercalcemia (15%), hypervolemia (12%) Common (1% to 10%): Anorexia, hyperkalemia [Ref] There are reports from clinical trials of significant hypertriglyceridemia associated with high doses of levocarnitine (3 g/day) given to uremic dialysis patients
Lipotropic compounds help the body process and transport fats more efficiently , which can support patients who are working toward weight management and metabolic health
While many of these supplements are widely used and generally considered safe when supervised by a healthcare provider, scientific evidence varies, and individual responses can differ
On average, individuals using FDA-approved medications may lose 15-20% of their body weight over several months when combined with a healthy diet and regular exercise
We present here the crystal structure of TyrBm with KA bound in the active site at 2.6 resolution (Fig
Emerging drying techniques for food safety and quality: A review
